[1］Bombardelli E. Pharmaceutical and cosmetic compositions containing complexes of flavanoligans with phospholipids［P］. Europe Patent .300,282,1987-07-10. [2］马云淑，赵浩如，林以宁.葛根素及其磷脂复合物的体外透皮实验研究［J］.中国中药杂志，2000，25（5）：274. [3］江永南，陈济民，余子培，等.淫羊藿黄酮磷脂复合物的制备及其剂型研究［J］.2000中国药学会学术年会论文集,宁波：中国药学会，2000:798. [4］Lieberman S, Pasad VVK,Ponticorvo L.Complexes of lipilid compounds with nonlipohilic ionic pharmaceutical active agent［P］.US Patent:4 780 455,1988-10-25. [5］Bombardelli E, Magistretti MJ. Pharmaceutical compositions containing flavanolignans and phospholipids as active principles［P］. Europe Patent : 209 037,1985-07-17. [6］Gabetta B, Bombardelli E, Pifferi G. Complexes of flavanolignans with phospholipids,preparation thereof and associated pharmaceutical compositions［P］.Europe Patent:209 038,1986-07-07. [7］Bombardelli E , Patri G. Complexes of glycyrrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them［P］.US Patent:5 147 859,1988-07-17. [8］Bombardelli E,Patri G,Pozzi R. Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them［P］.Europe Patent:283 713,1988-02-18. [9］沈建民，武振卿.药物结构与制剂［M］.北京：中国医药科技出版社，1989：94；380. [10］Venkataram S, Ragers JA. Characterristics of drug-phospholipid coprecipitates Ⅰ:physical properties and dissolution behavior of griseofulin-dimyristoylphosphatidylcholine systems［J］. J Pharm Sci ,1984,73(6):757. [11］Bombardelli E,Cristoni A,Morazzoni P.Phytosomes in functional cosmetics［J］. Fitoteapia ,1994,65(5):387. [12］Radhakrishnan A, Mcconnell HM. Electric field effect on cholesterol-phospholipid complexes［J］. Proc Natl Acad Sci USA ,2000,97(3):1073. [13］Dobretsov GE,Dergunor AD,Taveivne J, et al .Apolipoprotein localization in reconstituted HPL particles: fluorescence energy transfer study［J］. Chem Phys Lipids ,1998,97(1):65. [14］Buroru M.Adjuvant-lipid complexes for use as modified adjuvants in preparing vaccines［P］.Japan Patent:02 92 996,1990-04-03. [15］Parikh I.Novel adjuvant compositions and vaccine formulations comprising same［P］.PCT Int Appl WO:97 01 330,1995-06-26. [16］Benetollo C ,Lambert G,Talussot C, et al .Lipid-binding properyies of synthetic peptide fragments of human apolipoprotein A-II［J］. Eur J Biochem ,1996,242(3):657. [17］Shah P,Nilsson J,Kanl S, et al .Effects of recombinant apolipoprotein A-IMilane on aortic Atherosclerosis in apolipoprotein E-deficient mice［J］. Circulation ,1998,97(8):780. [18］Vazquez C,Calabrese JC,Dixon DA, et al .Synthesis and characterization of the strongest isolated electron acceptor and its reduced forms［J］. J Org Chem ,1993,58(1):65. [19］Choerian M.Lipid complexes and liposomes of highly insoluble platium complexes［P］. PCT Int Appl WO :98 33 481,1998-08-06. [20］Wu FJ,Flach CR ,Seaton BA, et al .Stability of annexin V in ternary complexes with Ca2+ and anoinic phospholipids:IR studies of monolayer and buik phases［J］. Biochem ,1999,38(2):792. [21］马云淑，赵浩如，林以宁.丹皮酚及其磷脂复合物的体外透皮初步研究［J］.云南中医中药杂志，1999，20（4）：36. [22］Wu JM, Chen DW, Zhang RH.Study on the bioavailability of baicalin-phospholipid complex by using HPLC ［J］. Biomed Chromatogr ,1999,13(7):493. [23］Pietta P, Simonetti P, Gardana C, et al .Relationship between rate and extend of catechin absorption and plasma antioxidant status ［J］. Biochem Mol Biol Int ,1998,46(5):895. [24］杜海燕.水飞蓟素-磷脂复合物对高脂肪饮食家兔的保肝作用［J］.国外医学·中医中药分册，1998，20(1)：44. [25］Gatti G,Peruua E.Plasma concentrations of free and conjugated silybin after oral intake of a silybin- phosphatidylcholine complexe in healthy volunteers［J］. Int J Clin Pharmacol Ther ，1994，32（11）：614. [26］Quaglino D，Pasquali RI，Mori G， et al .Hyalurnan-phospholipid interactions［J］. J Struct Biol ，1997，120（1）：1. [27］Radhakrishnan A，Mcconnell HM.Cholesterol-phospholipid complexes in membranes［J］. J Am Chem Sci ，1999，121（2）：486. [28］Frankenburg S, Glick D, Klaus S, et al .Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B［J］. Antimicrob Agents Chemother ,1998,42(12):3092.